U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515105) titled 'Gluten Free Oat (Cultivar Saul) in Celiac Disease in Remission' on March 20.
Brief Summary: The goal of this clinical trial is to evaluate the tolerability of the oat cultivar Saul, previously characterized by low celiac disease-related immunoreactivity, in adults with celiac disease in sustained clinical and immunological remission The main question the study aims to answer is whether consumption of gluten-free oats of the Saul variety leads to changes in patient-reported symptoms and serological markers.
Participants consumed50 g of gluten-free oat flakes daily for 14 consecutive days.
Study Start Date: Jan. 07, 2022
Study Type...